metsera glp 1 GLP-1 start-up launches with $290 million Pfizer to buy weight-loss drug

Patients with obesity and metabolic syndrome : Weight reduction achieved through GLP-1 therapy often correlates with improvements in the characteristic dyslipidaemia of metabolic syndrome (elevated triglycerides, low HDL cholesterol, and small dense LDL particles)

JAMA (2020) 323(6):54860

OR To continue reading Password required to log in Introduction The quest for more physiologic approaches to augment insulin treatment prompted investigation of glucoregulatory hormones

Safety Considerations and NHS Guidance on Berberine Whilst berberine appears generally well-tolerated in short-term studies (often using doses of 500 mg two to three times daily), several important safety considerations warrant attention

Besides hydrophobic and acidic acylations, hydroxylated acyl groups including -hydroxybutyryl and 2-hydroxyisobutyryl modifications have been recently identified 41,42

& Merchenthaler, I